Results
Awaiting price reaction for this filing.
Dolphin Medical Services reported FY25 revenue from operations of ₹77.94 lakhs, up about 15% from ₹67.86 lakhs in FY24. Despite the top-line growth, the company posted a net loss of ₹3.38 lakhs for FY25, though this was a sharp improvement from a ₹10.40 lakh loss in FY24. Q4 FY25 also saw a narrower loss of ₹7.00 lakhs versus ₹13.29 lakhs in Q4 FY24. Total expenses rose to ₹84.66 lakhs, and depreciation plus other costs kept profits under pressure. The balance sheet shows negative reserves of ₹506.04 lakhs against paid-up equity of ₹1,510 lakhs, leaving total equity at about ₹1,004 lakhs. Cash from operations remained negative at ₹5.97 lakhs, though cash balance edged up to ₹2.02 lakhs. The auditor issued an unmodified (clean) opinion on the results.
Losses are shrinking and revenue is growing modestly, which is a mild positive for shareholders, but the company is still loss-making with negative reserves and negative operating cash flow, signaling ongoing financial fragility. The clean audit opinion provides some comfort, but investors should watch closely for a return to profitability.